B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ic261

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ic261, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cgs
2 shared targets
galunisertib
2 shared targets
azd
2 shared targets
seliciclib
2 shared targets
sb
2 shared targets
tg100
2 shared targets
milciclib
2 shared targets
bms
2 shared targets
bi
2 shared targets
cyc
2 shared targets
Loading evidence profile...

This evidence profile for Ic261 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.